Skip to main content

Biologische Erkennung eines Prolaktin-Daunomycin-Liganden in vitro und in vivo

  • Conference paper
Mammakarzinome. Neue Perspektiven experimenteller und klinischer Therapieforschung
  • 19 Accesses

Zusammenfassung

Die Aufnahme eines Peptidhormons in die Zelle ist ein spezifischer Vorgang, der an die Präsenz des entsprechenden Rezeptors an der Zelloberfläche gebunden ist. Nach Erkennung und Komplexbildung werden die Hormonrezeptorkomplexe in Gruppen oder Clustern in Form eines endozytotischen Vesikels in die Zelle aufgenommen. Dieser Vorgang dient der Metabolisierung des Hormons, und bei einigen Hormonen, wie z.B. dem Prolaktin, auch der Metabolisierung des Rezeptors [101.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Blossey HC, Gaier B, Kohen F (1984) Properties of a prolactin-daunomycin (PRL-D) conjugate with intact hormone specificity. Proc. 7th Int Congr Endocrinology. Excerpta Medica, Amsterdam, p 423

    Google Scholar 

  2. Blossey HC, Gaier B, Zaltsman Y, Kohen F (1985) Prolactin-daunomycin conjugate inhibits in vitro growth and DNA synthesis in cells carrying the prolactin receptor. In: MacLeod RM, Thorner MO, Scapagnini U (eds) Prolactin. Basic and clinical correlates. Fidia Research Series vol I, Liviana Press, Padova, pp 367–373

    Google Scholar 

  3. Blossey HC, Gaier B, Zaltsman Y, Kohen F (to be published) Biologic activity and in vitro toxicity of a prolactin-daunomycin conjugate. Mol Cell Endocrinol

    Google Scholar 

  4. Bradford MM (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye binding. Analyt Biochem 72:248–254

    Article  PubMed  CAS  Google Scholar 

  5. Crooke ST, Duvernay VH, Mong S (1981) Molecular pharmacology of anthacyclines. In: Sartorelli AC, Lazo JS, Bertino JR (eds) Molecular actions and targets for cancer chemotherapeutic agents. Academic Press, New York London Toronto Sydney San Francisco, pp 137–162

    Google Scholar 

  6. Djiane J, Kelly PA, Houdebine LM (1980) Effects of lysosomotropic agents, cytochalasin B and colchicine on the „down-regulation“of prolactin receptors in mammary gland expiants. Molecular and Cellular Endocrinology 18:87–98

    Article  PubMed  CAS  Google Scholar 

  7. Josefsberg Z, Posner BI, Patel B, Bergeron JJM (1979) The uptake of prolactin into female rat liver. Concentration of intact hormone in the Golgi apparatus. The Journal of Biological Chemistry 254:209–214

    PubMed  CAS  Google Scholar 

  8. Lindner HR, Kohen F, Amsterdam A (1980) An approach to site-directed chemotherapy of hormone-sensitive cancer. In: Iacobelli S, King RJB, Lippman ME, Lindner HR (eds): Hormones and cancer. Raven Press, New York, pp 541–550

    Google Scholar 

  9. Osborne CK, Hamilton B, Nover M (1982) Receptor binding and processing of epidermal growth factor by human breast cancer cells. J Clin Endocrinol Metab 55:86–94

    Article  CAS  Google Scholar 

  10. Posner BI, Bergeron JJM, Josefsberg Z, Khan MN, Khan RJ, Patel BA, Sikstrom RA, Verma AK (1981) Polypeptide hormones: Intracellular receptors and internalization. Recent Progress in Hormone Research. 37:539–581

    PubMed  CAS  Google Scholar 

  11. Rogol AD, Chrambach A (1975) Radioiodinated human pituitary and amniotic fluid prolactin with preserved molecular integrity. Endocrinology 97:406–417

    Article  PubMed  CAS  Google Scholar 

  12. Scatchard G (1949) The attraction of proteins for small molecules and ions. Annals of the New York Academy of Sciences 51:660–672

    Article  CAS  Google Scholar 

  13. Tritton TR, Yee G (1982) The anticancer agent adriamycin can be actively cytotoxic without entering cells. Science 217:248–250

    Article  CAS  Google Scholar 

  14. Turcot-Lemay L, Kelly PA (1982) Prolactin receptors in human breast tumors. J Natn Cancer Inst 68:381–383

    CAS  Google Scholar 

  15. Varga JM, Asato N, Lande S, Lerner AB (1977) Melanotropin-daunomycin conjugate shows receptor-mediated cytotoxicity in cultured murine melanoma cells. Nature 267:56–58

    Article  PubMed  CAS  Google Scholar 

  16. Wang C, Hsueh AJW, Erickson GF (1979) Induction of functional prolactin receptors by follicle-stimulating hormone in rat granulosa cells in vivo and in vitro. The Journal of Biological Chemistry 254:11330–11336

    PubMed  CAS  Google Scholar 

  17. Wiesehahn G, Varga JM, Hearst JE (1981) Interactions of daunomycin and melanotropin-daunomycin with DNA. Nature 292:467–469

    Article  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Blossey, H.C., Gaier, B., Zaltsman, Y., Kohen, F. (1986). Biologische Erkennung eines Prolaktin-Daunomycin-Liganden in vitro und in vivo. In: Nagel, G.A. (eds) Mammakarzinome. Neue Perspektiven experimenteller und klinischer Therapieforschung. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71041-4_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-71041-4_16

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-71042-1

  • Online ISBN: 978-3-642-71041-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics